Business

Wellgistics Health Converts $8.1M Debt to Equity

TAMPA, FLORIDA / ACCESS Newswire / July 25, 2025 /Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, ...

articleWellgistics Health, Inc.July 25, 20253/company/wellgistics-health-inc-common-stock/news/wellgistics-health-converts-dollar81m-debt-to-equity
Wellgistics Health Converts $8.1M Debt to Equity

About this update from Wellgistics Health, Inc.

[{"type":"text","content":"TAMPA, FLORIDA / ACCESS Newswire / July 25, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced that its Board of Directors has approved an $8.1 million debt-to-equity conversion.","length":369,"tagName":"p"},{"type":"text","content":"Led by CEO Brian Norton and former minority partners of Wellgistics, LLC, which was acquired by Wellgistics Health in 2024, the transaction strengthens the Company's balance sheet by materially reducing the Company's short-term debt.","length":241,"tagName":"p"},{"type":"text","content":"The transaction is also expected to:","length":36,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Accelerate the Company's cash flow by unlocking more favorable terms and capital access;","length":92,"tagName":"p"}]},{"val":[{"type":"text","content":"Improve Wellgistics Health's ability to acquire high-demand pharmaceutical products at competitive prices;","length":110,"tagName":"p"}]},{"val":[{"type":"text","content":"Expand the Company's national footprint by growing its network of independent pharmacies; and","length":97,"tagName":"p"}]},{"val":[{"type":"text","content":"Strengthen the Company's proprietary technology platform, including AI-powered hub services and digital prescription routing","length":128,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":427,"olType":false},{"type":"text","content":""This conversion will make a significant contribution in enabling us to accelerate our business plan and accomplish the goals we believe will help transform the prescription drug marketplace and drive long-term value for our shareholders," said Wellgistics Health CFO Mark DiSiena.","length":291,"tagName":"p"},{"type":"text","content":""We look forward to sharing additional positive developments in the near future."","length":91,"tagName":"p"},{"type":"text","content":"About Wellgistics Health","length":24,"tagName":"p"},{"type":"text","content":"Wellgistics Health (NASDAQ: WGRX) delivers medications from manufacturer to patient-faster, smarter, and more affordably. Its integrated platform connects 6,500+ independent pharmacies and 200+ U.S. manufact...

More updates from Wellgistics Health, Inc.

pharmaceutical distributionForward-Looking Statementsindependent pharmaciesHealth